The fair value estimate on Veeva Systems has been trimmed slightly from US$312.18 to US$310.98 per share, with the discount rate edging up from 8.20% to 8.23% and revenue growth assumptions adjusted ...
Zacks Investment Research on MSN
Veeva Systems (VEEV) stock sinks as market gains: What you should know
Veeva Systems (VEEV) closed at $233.21 in the latest trading session, marking a -2.88% move from the prior day. This change ...
Zacks Investment Research on MSN
Wall Street analysts think Veeva (VEEV) is a good investment: Is it?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a ...
What if you'd invested in Veeva Systems (VEEV) ten years ago? It may not have been easy to hold on to VEEV for all that time, ...
"With Veeva Environmental Monitoring, we are further expanding on our long-term commitment to streamline and modernize ...
Veeva Systems and BioMarin Pharmaceutical have announced an enterprise agreement intended to build upon their long-standing ...
Veeva Systems shares were 7% higher, at $235.89, after the company said its board of directors approved a share-repurchase program with authorization to buy up to $2 billion of its shares.
Zacks.com on MSN
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
Detailed price information for Veeva Systems Inc (VEEV-N) from The Globe and Mail including charting and trades.
Veeva Systems is executing well its migration plan from Salesforce to Veeva Vault CRM, positioning itself for double-digit revenue growth. Better than expected Q2 2023 results with revenue of $590.2 ...
Veeva Systems has outperformed peers with strong momentum and a Q1 beat, but its valuation remains stretched at 13x revenue and 37x P/E. Despite robust fundamentals—market share opportunity, vendor ...
The cloud-based software company has driven strong growth by focusing on executing a simple concept well. The impressive stock performance of this cloud-based software company is not an accident. One ...
Top-line growth rates at the cloud computing company have dropped recently. Still, Veeva's prospects remain intact for investors focused on the long game. The life sciences-focused, cloud-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results